World first as MHRA approves trofolastat for diagnostic imaging of prostate cancer in men

World first as MHRA approves trofolastat for diagnostic imaging of prostate cancer in men

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved trofolastat (RoTecPSMA), the first prostate-specific membrane antigen (PSMA)-targeti... Read More
ADS

DISCLOSURE: We may earn a commission when you use one of our coupons/links to make a purchase.